StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.41−0.09 (-6.00%)

Close on Nov 12, 2026Market cap $35.81MP/E –Yield –

Serina Therapeutics statistics

63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 12, 2026 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$38.10M
$289.51M
Enterprise Value
$18.70M
$155.84M
PB Ratio
2.74
2.10
P/TBV Ratio
2.74
2.34

Share statisticsIndustry

Shares Change (YoY)
64.5%
10.9%
Shares Change (QoQ)
3.96%
0.48%
Float
13M
49M
Shares Held by Insiders
49.7%
12.1%
Shares Held by Institutions
5.54%
56.4%

Short sellingIndustry

Short Interest
46,787
–
Short Interest Change
6.65%
-0.80%
Short % of Float
0.37%
9.06%
Short % of Shares Outstanding
0.18%
6.30%
Days to Cover
1.00
5.15

Stock price statisticsIndustry

52-Week High
$4.31
–
52-Week Low
$1.14
–
20-Day Moving Average
$1.68
–
50-Day Moving Average
$1.99
–
200-Day Moving Average
$2.04
–
Average True Range (14)
$0.25
–
Price Change (1 Week)
-11.2%
0.17%
Price Change (1 Month)
-17.6%
-1.30%
Price Change (3 Months)
-47.4%
-19.3%
Price Change (6 Months)
-3.85%
-20.2%
Price Change (YTD)
-21.6%
-21.3%
Price Change (1 Year)
-62.4%
-20.6%
Price Change (3 Years)
147.1%
-22.2%
Price Change (5 Years)
85.2%
-76.5%
Average Volume (10 Days)
99,651
–
Average Volume (20 Days)
72,071
–
Average Volume (90 Days)
65,199
–
Relative Volume
0.27
0.74
Relative Strength Index (14)
37.8
46.2
Volatility (1 Year)
139.6%
80.2%
Beta (5 Years)
-1.09
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-312.5%
-51.3%
Return on Assets (ROA)
-142.9%
-40.7%

Financial positionIndustry

Current Ratio
4.62
3.30
Quick Ratio
4.28
2.40

GrowthIndustry

Revenue Growth (3Y CAGR)
56.4%
2.25%
Revenue Growth (5Y CAGR)
-18.5%
6.41%

EfficiencyIndustry

Profits Per Employee
-$1.53M
-$683.67K
Employee Count
16
75
WACC
7.38%
10.1%

Income statement (TTM)Industry

Net Income
-$24.50M
-$21.61M
EPS (Diluted)
-$1.76
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$19.40M
$16.56M
Net Cash Per Share
$0.76
$0.71
Equity (Book Value)
$13.92M
$52.23M
Book Value Per Share
$0.55
$1.50
Tangible Book Value
$13.92M
$26.10M
Working Capital
$16.40M
$78.41M

Cash flow (TTM)Industry

Operating Cash Flow
-$22.78M
-$12.27M
Capital Expenditures
-$56.00K
-$944.00K
Free Cash Flow
-$22.84M
-$18.20M
FCF Per Share
-$0.90
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-64.3%
-20.1%
FCF Yield
-59.9%
-9.18%

Taxes and interestIndustry

Interest Expense
$794.00K
$2.98M

Scores and fair valueIndustry

Altman Z-Score
-1.64
0.31
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodSERS&P 500DifferenceSER per yearS&P 500 per year
1 month-27.3%-2.7%−24.6 pts
3 months-50.0%-1.7%−48.3 pts
Year to date-26.3%+11.9%−38.2 pts
1 year-64.9%+12.0%−76.9 pts
3 years+137.8%+78.2%+59.6 pts+33.5%+21.2%
5 years+74.1%+73.2%+0.8 pts+11.7%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M SER shares were sold short on Oct 30, 2026, up 6.6% from the previous report, or 0.37% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 34.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202646,787+6.6%58,0851.0
Oct 15, 202643,870-22.5%38,4921.1
Sep 30, 202656,600-52.6%121,0921.0
Sep 15, 2026119,360+70.3%82,8641.4
Aug 31, 202670,094-51.8%53,1721.3
Aug 14, 2026145,548-34.7%69,2052.1
Jul 31, 2026222,920-21.7%26,0878.6
Jul 15, 2026284,546-0.3%54,3945.2
Jun 30, 2026285,430-25.7%82,5593.5
Jun 15, 2026383,983+11.3%182,4662.1
May 29, 2026345,042+6.8%91,9743.8
May 15, 2026323,055+9.9%79,4144.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?